Exagen (XGN) Free Cash Flow Growth (3y) (2021 - 2026)
Exagen (XGN) Free Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 44.40% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -13.58% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 14.59% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -16.15% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 24.73% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 29.96% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 99.80% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -2.01% |
| 10 | Exagen | 100.67 Mn | 79.16 Mn | 10.21 Mn | -1.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.62% |
| Dec 31, 2025 | 16.02% |
| Sep 30, 2025 | 34.44% |
| Jun 30, 2025 | 38.19% |
| Mar 31, 2025 | -3.73% |
| Dec 31, 2024 | 26.68% |
| Sep 30, 2024 | 24.99% |
| Jun 30, 2024 | 17.10% |
| Mar 31, 2024 | -27.96% |
| Dec 31, 2023 | 59.04% |
| Sep 30, 2023 | -11.07% |
| Jun 30, 2023 | -30.42% |
| Mar 31, 2023 | -44.85% |
| Dec 31, 2022 | -20.04% |
| Sep 30, 2022 | -65.50% |
| Jun 30, 2022 | -72.98% |
| Mar 31, 2022 | -70.13% |
| Dec 31, 2021 | -47.11% |